Berrak zihinler için yalın, zengin, bağımsız bir Türkçe dijital medya üyeliği.
Ücretsiz Kaydol →
viral ile ilgili hikayeler
• Novartis is looking to obtain expedited approval for the use of their antiviral drug after trials on Covid-19 patients yielded encouraging results. The numbers: Novartis’ antiviral ensovibep was 78 percent effective in reducing the risk of death, hospitalization, or emergency room visits in Phase 2 trials.
11 Oca 2022